Tiger Brokers

ACOTEC-B (06669) Schedules 26 March 2026 Board Meeting to Approve FY2025 Audited Results and Consider Final Dividend

Bulletin Express
Mar 16

Acotec Scientific Holdings Limited (stock code 06669, “ACOTEC-B”) has announced that its board of directors will convene on 26 March 2026. The agenda includes:

• Reviewing and approving the audited consolidated results of ACOTEC-B and its subsidiaries for the financial year ended 31 December 2025.

• Deliberating on the declaration and payment of a final dividend, if any, for the period under review.

The meeting will be chaired by Executive Director and Chief Executive Officer Ms. Jing Li, who also serves as Chairperson of the Board. The current board comprises one executive director, three non-executive directors, and three independent non-executive directors.

The company plans to release its audited annual results to the market following board approval on the meeting date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10